Evidence map›Paper›PMID 33853805›Full record

ArticleBMJ open2021

Changes in quality of life (QoL) and other patient-reported outcome measures (PROMs) in living-donor and deceased-donor kidney transplant recipients and those awaiting transplantation in the UK ATTOM programme: a longitudinal cohort questionnaire survey with additional qualitative interviews.

Andrea Gibbons, Janet Bayfield, Marco Cinnirella, Heather Draper, Rachel J Johnson, Gabriel C Oniscu, Rommel Ravanan, Charles Tomson, Paul Roderick, Wendy Metcalfe and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Andrea GibbonsDepartment of Psychology, University of Winchester, Winchester, UK.ORCID 0000-0002-7774-0563
Janet BayfieldHealth Psychology Research Unit, Royal Holloway University of London, Egham, UK.
Marco CinnirellaDepartment of Psychology, Royal Holloway, University of London, Egham, UK.
Heather DraperHealth Sciences, University of Warwick, Warwick Medical School, Coventry, UK.
Rachel J JohnsonStatistics and Clinical Studies, NHS Blood and Transplant, Bristol, UK.
Gabriel C OniscuEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Rommel RavananRichard Bright Renal Unit, Southmead Hospital, Bristol, UK.
Charles TomsonDepartment of Renal Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Paul RoderickAcademic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Wendy MetcalfeEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
John L R ForsytheEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
Christopher DudleyRichard Bright Renal Unit, Southmead Hospital, Bristol, UK.
Christopher J E WatsonDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0590-4901
J Andrew BradleyDepartment of Surgery, University of Cambridge, Cambridge, UK.
Clare BradleyHealth Psychology Research Unit, Royal Holloway University of London, Egham, UK cb@healthpsychologyresearch.com.ORCID 0000-0002-4079-0364
Royal Holloway University of London · GBEdinburgh Royal Infirmary · GBNHS Blood and Transplant · GBSouthmead Hospital · GBUniversity of Cambridge · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversity of Southampton · GBUniversity of Warwick · GBUniversity of Winchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine quality of life (QoL) and other patient-reported outcome measures (PROMs) in kidney transplant recipients and those awaiting transplantation.

designLongitudinal cohort questionnaire surveys and qualitative semi-structured interviews using thematic analysis with a pragmatic approach.

settingCompletion of generic and disease-specific PROMs at two time points, and telephone interviews with participants UK-wide.

participants101 incident deceased-donor (DD) and 94 incident living-donor (LD) kidney transplant recipients, together with 165 patients on the waiting list (WL) from 18 UK centres recruited to the Access to Transplantation and Transplant Outcome Measures (ATTOM) programme completed PROMs at recruitment (November 2011 to March 2013) and 1 year follow-up. Forty-one of the 165 patients on the WL received a DD transplant and 26 received a LD transplant during the study period, completing PROMs initially as patients on the WL, and again 1 year post-transplant. A subsample of 10 LD and 10 DD recipients participated in qualitative semi-structured interviews.

resultsLD recipients were younger, had more educational qualifications and more often received a transplant before dialysis. Controlling for these and other factors, cross-sectional analyses at 12 months post-transplant suggested better QoL, renal-dependent QoL and treatment satisfaction for LD than DD recipients. Patients on the WL reported worse outcomes compared with both transplant groups. However, longitudinal analyses (controlling for pre-transplant differences) showed that LD and DD recipients reported similarly improved health status and renal-dependent QoL (p<0.01) pre-transplant to post-transplant. Patients on the WL had worsened health status but no change in QoL. Qualitative analyses revealed transplant recipients' expectations influenced their recovery and satisfaction with transplant.

conclusionsWhile cross-sectional analyses suggested LD kidney transplantation leads to better QoL and treatment satisfaction, longitudinal assessment showed similar QoL improvements in PROMs for both transplant groups, with better outcomes than for those still wait-listed. Regardless of transplant type, clinicians need to be aware that managing expectations is important for facilitating patients' adjustment post-transplant.

Indexed as

Kidney TransplantationQuality of LifeCross-Sectional StudiesHumansLiving DonorsPatient Reported Outcome MeasuresRenal DialysisSurveys and QuestionnairesUnited Kingdomchronic renal failuredialysisnephrologypatient-reported outcome measuresquality of liferenal transplantationtransplant medicinetransplant surgery

Identifiers

PMID33853805
PMCPMC8098938
OpenAlexW3155079640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.